1. Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial. Issue 8 (17th December 2007) Authors: Genant, H K; Peterfy, C G; Westhovens, R; Becker, J-C; Aranda, R; Vratsanos, G; Teng, J; Kremer, J M Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 8(2008) Page Start: 1084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Issue 2 (8th April 2009) Authors: Greenberg, J D; Reed, G; Kremer, J M; Tindall, E; Kavanaugh, A; Zheng, C; Bishai, W; Hochberg, M C Journal: Annals of the rheumatic diseases Issue: Volume 69:Issue 2(2010) Page Start: 380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide. Issue 01 (15th January 2009) Authors: Curtis, J R; Beukelman, T; Onofrei, A; Cassell, S; Greenberg, J D; Kavanaugh, A; Reed, G; Strand, V; Kremer, J M Journal: Annals of the rheumatic diseases Issue: Volume 69:Issue 01(2010) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690, 550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial. Issue 2 (8th July 2009) Authors: Coombs, J H; Bloom, B J; Breedveld, F C; Fletcher, M P; Gruben, D; Kremer, J M; Burgos-Vargas, R; Wilkinson, B; Zerbini, C A F; Zwillich, S H Journal: Annals of the rheumatic diseases Issue: Volume 69:Issue 2(2010) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Let's re-examine these MTX points once again. Issue 8 (10th June 2016) Authors: Kremer, J M Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 8(2016) Page Start: e54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Methotrexate pharmacogenomics. Issue 9 (11th August 2006) Authors: Kremer, J M Journal: Annals of the rheumatic diseases Issue: Volume 65:Issue 9(2006) Page Start: 1121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Significant symptomatic improvement of subacute cutaneous lupus after testosterone therapy in a female-to-male transgender subject. (February 2018) Authors: Ocon, A; Peredo-Wende, R; Kremer, J M; Bhatt, B D Journal: Lupus Issue: Volume 27:Number 2(2018) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗